FormWeb • telmisartan-amLODIPine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

telmisartan-amLODIPine

telmisartan-amLODIPine

Non-formulary ARB Combination Products Formulary
Non-formulary Miscellaneous Program Formulary
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Twynsta	TABLET, ORAL	40 mg-5 mg, 80 mg-5 mg
Twynsta	TABLET, ORAL	40 mg-10 mg, 80 mg-10 mg

VIEW MORE Dihydropyridines, Angiotensin II Receptor Antagonists

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

telmisartan-amLODIPine (Twynsta)

40 mg-5 mg tablet oral
40 mg-10 mg tablet oral

losartan (Cozaar) AND amLODIPine (Norvasc)

ONE 100 mg losartan PLUS ONE 5 mg amLODIPine
ONE 100 mg losartan PLUS ONE 10 mg amLODIPine

telmisartan-amLODIPine (Twynsta)

80 mg-5 mg tablet oral
80 mg-10 mg tablet oral

valsartan (Diovan) AND amLODIPine (Norvasc)

ONE 320 mg valsartan PLUS ONE 5 mg amLODIPine
ONE 320 mg valsartan PLUS ONE 10 mg amLODIPine

Reviewed: April 27, 2010

Last updated: Dec. 26, 2017

Black Box Warning: Telmisartan: pregnancy risk

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.